Selected research
Industry Research
Non-injectable GnRH Drugs Industry Research Report 2026
Market perspective
The global Non-injectable GnRH Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Non-injectable GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Non-injectable GnRH Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Non-injectable GnRH Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Non-injectable GnRH Drugs include Sanofi, Pfizer, Abbvie, Sumitomo Pharma, ObsEva, Neon Healthcare, JW Pharmaceutical, Fuji Pharma and ASKA Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Non-injectable GnRH Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-injectable GnRH Drugs Market by Company
Sanofi
Pfizer
Abbvie
Sumitomo Pharma
ObsEva
Neon Healthcare
JW Pharmaceutical
Fuji Pharma
ASKA Pharmaceutical
Non-injectable GnRH Drugs Segment by Type
Tablets
Nasal Spray
Others
Non-injectable GnRH Drugs Segment by Application
Menorrhagia
Central Precocious Puberty
Uterine Fibroids
Endometriosis
Other
Non-injectable GnRH Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-injectable GnRH Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-injectable GnRH Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-injectable GnRH Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Non-injectable GnRH Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Non-injectable GnRH Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Non-injectable GnRH Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Nasal Spray
- Others
Applications
- Menorrhagia
- Central Precocious Puberty
- Uterine Fibroids
- Endometriosis
- Other
Companies covered
- Sanofi
- Pfizer
- Abbvie
- Sumitomo Pharma
- ObsEva
- Neon Healthcare
- JW Pharmaceutical
- Fuji Pharma
- ASKA Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Non-injectable GnRH Drugs Market Size (2021-2032)
- 2.2.2 Global Non-injectable GnRH Drugs Sales (2021-2032)
- 2.2.3 Global Non-injectable GnRH Drugs Market Average Price (2021-2032)
- 2.3 Non-injectable GnRH Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Nasal Spray
- 2.3.4 Others
- 2.4 Non-injectable GnRH Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Menorrhagia
- 2.4.3 Central Precocious Puberty
- 2.4.4 Uterine Fibroids
- 2.4.5 Endometriosis
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Non-injectable GnRH Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Non-injectable GnRH Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Non-injectable GnRH Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Non-injectable GnRH Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Non-injectable GnRH Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Non-injectable GnRH Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Non-injectable GnRH Drugs, Product Type & Application
- 3.8 Global Manufacturers of Non-injectable GnRH Drugs, Established Date
- 3.9 Global Non-injectable GnRH Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Non-injectable GnRH Drugs Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Non-injectable GnRH Drugs Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Abbvie
- 4.3.1 Abbvie Company Information
- 4.3.2 Abbvie Business Overview
- 4.3.3 Abbvie Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abbvie Non-injectable GnRH Drugs Product Portfolio
- 4.3.5 Abbvie Recent Developments
- 4.4 Sumitomo Pharma
- 4.4.1 Sumitomo Pharma Company Information
- 4.4.2 Sumitomo Pharma Business Overview
- 4.4.3 Sumitomo Pharma Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sumitomo Pharma Non-injectable GnRH Drugs Product Portfolio
- 4.4.5 Sumitomo Pharma Recent Developments
- 4.5 ObsEva
- 4.5.1 ObsEva Company Information
- 4.5.2 ObsEva Business Overview
- 4.5.3 ObsEva Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 ObsEva Non-injectable GnRH Drugs Product Portfolio
- 4.5.5 ObsEva Recent Developments
- 4.6 Neon Healthcare
- 4.6.1 Neon Healthcare Company Information
- 4.6.2 Neon Healthcare Business Overview
- 4.6.3 Neon Healthcare Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Neon Healthcare Non-injectable GnRH Drugs Product Portfolio
- 4.6.5 Neon Healthcare Recent Developments
- 4.7 JW Pharmaceutical
- 4.7.1 JW Pharmaceutical Company Information
- 4.7.2 JW Pharmaceutical Business Overview
- 4.7.3 JW Pharmaceutical Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 JW Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
- 4.7.5 JW Pharmaceutical Recent Developments
- 4.8 Fuji Pharma
- 4.8.1 Fuji Pharma Company Information
- 4.8.2 Fuji Pharma Business Overview
- 4.8.3 Fuji Pharma Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fuji Pharma Non-injectable GnRH Drugs Product Portfolio
- 4.8.5 Fuji Pharma Recent Developments
- 4.9 ASKA Pharmaceutical
- 4.9.1 ASKA Pharmaceutical Company Information
- 4.9.2 ASKA Pharmaceutical Business Overview
- 4.9.3 ASKA Pharmaceutical Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ASKA Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
- 4.9.5 ASKA Pharmaceutical Recent Developments
5 Global Non-injectable GnRH Drugs Market Scenario by Region
- 5.1 Global Non-injectable GnRH Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Non-injectable GnRH Drugs Sales by Region: 2021-2032
- 5.2.1 Global Non-injectable GnRH Drugs Sales by Region: 2021-2026
- 5.2.2 Global Non-injectable GnRH Drugs Sales by Region: 2027-2032
- 5.3 Global Non-injectable GnRH Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Non-injectable GnRH Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Non-injectable GnRH Drugs Revenue by Region: 2027-2032
- 5.4 North America Non-injectable GnRH Drugs Market Facts & Figures by Country
- 5.4.1 North America Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Non-injectable GnRH Drugs Sales by Country (2021-2032)
- 5.4.3 North America Non-injectable GnRH Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Non-injectable GnRH Drugs Market Facts & Figures by Country
- 5.5.1 Europe Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Non-injectable GnRH Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Non-injectable GnRH Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Non-injectable GnRH Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Non-injectable GnRH Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Non-injectable GnRH Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Non-injectable GnRH Drugs Market Facts & Figures by Country
- 5.7.1 South America Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Non-injectable GnRH Drugs Sales by Country (2021-2032)
- 5.7.3 South America Non-injectable GnRH Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Non-injectable GnRH Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Non-injectable GnRH Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Non-injectable GnRH Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Non-injectable GnRH Drugs Sales by Type (2021-2032)
- 6.1.1 Global Non-injectable GnRH Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Non-injectable GnRH Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Non-injectable GnRH Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Non-injectable GnRH Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Non-injectable GnRH Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Non-injectable GnRH Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Non-injectable GnRH Drugs Sales by Application (2021-2032)
- 7.1.1 Global Non-injectable GnRH Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Non-injectable GnRH Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Non-injectable GnRH Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Non-injectable GnRH Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Non-injectable GnRH Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Non-injectable GnRH Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Non-injectable GnRH Drugs Value Chain Analysis
- 8.1.1 Non-injectable GnRH Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Non-injectable GnRH Drugs Production Mode & Process
- 8.2 Non-injectable GnRH Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Non-injectable GnRH Drugs Distributors
- 8.2.3 Non-injectable GnRH Drugs Customers
9 Global Non-injectable GnRH Drugs Analyzing Market Dynamics
- 9.1 Non-injectable GnRH Drugs Industry Trends
- 9.2 Non-injectable GnRH Drugs Industry Drivers
- 9.3 Non-injectable GnRH Drugs Industry Opportunities and Challenges
- 9.4 Non-injectable GnRH Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst